title: Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.
abstract: The association between MMP1 -1607 1G>2G polymorphism and cancer risk has been reported, but results remained controversial and ambiguous. To assess the association between MMP1 -1607 1G>2G polymorphism and cancer risk, a meta-analysis was performed. Based on comprehensive searches of the PubMed, Elsevier Science Direct, Excerpta Medica Database (Embase), and Chinese Biomedical Literature Database (CBM), we identified outcome data from all articles estimating the association between MMP1 -1607 1G>2G polymorphism and cancer risk. The pooled odds ratio (OR) with 95% confidence intervals (CIs) were calculated. Thirty-eight studies involving 10178 cases and 9528 controls were included. Overall, significant association between MMP1 -1607 1G>2G polymorphism and cancer susceptibility was observed for additive model (OR = 1.21, 95% CI 1.09-1.35), for codominant model (OR = 1.34, 95% CI 1.10-1.63), for dominant model (OR = 1.17, 95% CI 1.01-1.34), for recessive model (OR = 1.31, 95% CI 1.14-1.52). In the subgroup analysis by ethnicity, the significant association was found among Asians but not among Caucasians. In the subgroup analysis by site of cancer, significant associations were found among lung cancer, colorectal cancer, head and neck cancer and bladder cancer. This meta-analysis demonstrated that the MMP1 -1607 1G>2G polymorphism was significantly associated with cancer risk.
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Guoda
authors.initials: G
authors.lastname: Han
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Zhijiang
authors.initials: Z
authors.lastname: Wei
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Zhiliang
authors.initials: Z
authors.lastname: Lu
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Haibin
authors.initials: H
authors.lastname: Cui
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Xiyong
authors.initials: X
authors.lastname: Bai
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Huai'e
authors.initials: H
authors.lastname: Ge
authors.affiliation: The First Department of Tumor Surgery, The Center Hospital of Cangzhou Cangzhou 061001, Hebei, P. R. China.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
keywords: Cancer; MMP1; genetics; meta-analysis